Category Archives: Protest&Campaigns
Petition by civil society to President Hollande on exorbitant prices of cancer drugs & demands transparency in pricing of innovative drugs
To fight the soaring prices of cancer medicines globally, French Cancer League last week initiated a petition to reiterates the following issues: Prices of cancer treatments are “unjustified, illegitimate, unacceptable & unsustainable” for the French public health system Medicines should … Continue reading
Iol news, Nobember 19, 2015. US and European pharmaceutical industries see South Africa as “ground zero” for keeping their large profit margins, say Julia Hill and Catherine Tomlinson.
Treatment Action Campaign; October 29, 2015. Cape Town/ Johannesburg – The Fix the Patent Laws (FTPL) Campaign, today called on the Department of Trade and Industry (DTI) to end years of pharmaceutical company price gouging and broken promises for patent law … Continue reading
Hepatitis C patients in Malaysia urgently need access to affordable Sofosbuvir. Help them by signing this petition to the Health Minister of Malaysia in the run-up to the International Harm Reduction Conference in Kuala Lumpur.
Source: Times of India 14 June 2015 MUMBAI: As the eighth round of negotiations on the Regional Comprehensive Economic Partnership (RCEP) trade agreement take place in Kyoto, Japan this week, farmer’s groups, trade unions, civil society and patient groups are … Continue reading
As RCEP begins in Japan, civil society groups launch campaign urging Indian PM to protect access to affordable drugs
Source: Pharmabiz 14 June 2015 Even as the eighth round of negotiations on the Regional Comprehensive Economic Partnership (RCEP) trade agreement take place in Kyoto, civil society and patient groups, including the international medical humanitarian organisation Médecins Sans Frontières (MSF) … Continue reading
Source: Reuters 14 June 2015 Charity Medecins Sans Frontieres appealed to India on Thursday not to give in to pressure from Europe, the United States and Japan to make it easier for big firms to get patents in the country, … Continue reading